216 related articles for article (PubMed ID: 25572159)
1. Substantia nigra hyperechogenicity in hypokinetic Huntington's disease patients.
Lambeck J; Niesen WD; Reinhard M; Weiller C; Dose M; Zucker B
J Neurol; 2015 Mar; 262(3):711-7. PubMed ID: 25572159
[TBL] [Abstract][Full Text] [Related]
2. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
3. Echogenicity of basal ganglia structures in different Huntington's disease phenotypes.
Saft C; Hoffmann R; Strassburger-Krogias K; Lücke T; Meves SH; Ellrichmann G; Krogias C
J Neural Transm (Vienna); 2015 Jun; 122(6):825-33. PubMed ID: 25503829
[TBL] [Abstract][Full Text] [Related]
4. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
Walter U; Wittstock M; Benecke R; Dressler D
J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
6. Transcranial sonography in Huntington's disease.
Krogias C; Eyding J; Postert T
Int Rev Neurobiol; 2010; 90():237-57. PubMed ID: 20692506
[TBL] [Abstract][Full Text] [Related]
7. Transcranial color-coded sonography helps differentiation between idiopathic Parkinson's disease and vascular parkinsonism.
Tsai CF; Wu RM; Huang YW; Chen LL; Yip PK; Jeng JS
J Neurol; 2007 Apr; 254(4):501-7. PubMed ID: 17401518
[TBL] [Abstract][Full Text] [Related]
8. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
[TBL] [Abstract][Full Text] [Related]
9. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
10. [Transcranial parenchymal sonography in the diagnosis of Parkinson's disease].
Mijajlović M; Petrović I; Stojković T; Svetel M; Stefanova E; Kostić VS
Vojnosanit Pregl; 2008 Aug; 65(8):601-5. PubMed ID: 18751340
[TBL] [Abstract][Full Text] [Related]
11. Preclinical substantia nigra dysfunction in rapid eye movement sleep behaviour disorder.
Miyamoto M; Miyamoto T; Iwanami M; Muramatsu S; Asari S; Nakano I; Hirata K
Sleep Med; 2012 Jan; 13(1):102-6. PubMed ID: 22033122
[TBL] [Abstract][Full Text] [Related]
12. Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease.
Berg D; Merz B; Reiners K; Naumann M; Becker G
Mov Disord; 2005 Mar; 20(3):383-5. PubMed ID: 15486999
[TBL] [Abstract][Full Text] [Related]
13. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.
Walter U; Dressler D; Wolters A; Wittstock M; Greim B; Benecke R
J Neurol; 2006 Apr; 253(4):448-54. PubMed ID: 16267638
[TBL] [Abstract][Full Text] [Related]
14. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography.
Postert T; Lack B; Kuhn W; Jergas M; Andrich J; Braun B; Przuntek H; Sprengelmeyer R; Agelink M; Büttner T
J Neurol Neurosurg Psychiatry; 1999 Oct; 67(4):457-62. PubMed ID: 10486391
[TBL] [Abstract][Full Text] [Related]
15. No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.
Lobsien E; Schreiner S; Plotkin M; Kupsch A; Schreiber SJ; Doepp F
Mov Disord; 2012 Mar; 27(3):450-3. PubMed ID: 22237792
[TBL] [Abstract][Full Text] [Related]
16. Long-term course of substantia nigra hyperechogenicity in Parkinson's disease.
Behnke S; Runkel A; Kassar HA; Ortmann M; Guidez D; Dillmann U; Fassbender K; Spiegel J
Mov Disord; 2013 Apr; 28(4):455-9. PubMed ID: 23115064
[TBL] [Abstract][Full Text] [Related]
17. [The neuroimaging features of Parkinson's disease and dystonia by transcranial sonography].
Xiao F; Zhang Y; Sheng Y; Chen X; Luo W; Mao C; Xiong K; Liu C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(15):1135-9. PubMed ID: 26081355
[TBL] [Abstract][Full Text] [Related]
18. Substantia nigra hyperechogenicity correlates with subtle motor dysfunction in tap dancers.
Ruprecht-Dörfler P; Klotz P; Becker G; Berg D
Parkinsonism Relat Disord; 2007 Aug; 13(6):362-4. PubMed ID: 17055330
[TBL] [Abstract][Full Text] [Related]
19. Transcranial ultrasound in different monogenetic subtypes of Parkinson's disease.
Schweitzer KJ; Brüssel T; Leitner P; Krüger R; Bauer P; Woitalla D; Tomiuk J; Gasser T; Berg D
J Neurol; 2007 May; 254(5):613-6. PubMed ID: 17415511
[TBL] [Abstract][Full Text] [Related]
20. Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.
Berg D
J Neural Transm (Vienna); 2011 Apr; 118(4):613-9. PubMed ID: 21207077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
